Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma

Li Shuang , Liu Hefang , Wang Ling , Zhu Changhong

Current Medical Science ›› 2006, Vol. 26 ›› Issue (32) : 111 -115.

PDF
Current Medical Science ›› 2006, Vol. 26 ›› Issue (32) : 111 -115. DOI: 10.1007/BF02828054
Article

Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma

Author information +
History +
PDF

Abstract

The effects of antisense oligodeoxynucleotide (antisense ODN) to follicle-stimulating hormone receptor (FSHR) and follicle-stimulating bormone (FSH) on the expression of proliferating cell nuclear antigen (PCNA) and vascular endothelial growth factor (VEGF) were studied in primary culture cells derived from human ovarian mucinous cystadenocarcinoma (OMC). The primary OMC cells were cultured with the enzyme digestion method, and the expression of pan Keratin protein and FSHR mRNA was detected for identification of the cells. OMC cells were co-cultured with antisense ODN, nonsense ODN and FSH with different concentrations for 48 h and 72 h. The expression of PCNA and VEGF was detected by using SP immunohistochemistry. Compared with that in the control group, the PCNA and VEGF expression was increased obviously in FSH groups (P<0.05 orP<0.01). while decreased significantly in antisense ODN groups (P<0.05 orP<0.01) and unchanged in nonsense ODN groups, respectively. Meanwhile, antisense ODN could antagonize the increased expression of PCNA and VEGF caused by FSH significantly (P<0.01). It was suggested that FSH might promote the development of OMC to some extent. Antisense ODN could inhibit the proliferative activity of OMC cells and the promoting proliferative activity enhanced by FSH.

Keywords

follicle stimulating hormone receptor / antisense oligodeoxynucleotide / ovarian neoplasm / proliferating cell nuclear antigen / vascular endothelial growth factor

Cite this article

Download citation ▾
Li Shuang, Liu Hefang, Wang Ling, Zhu Changhong. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma. Current Medical Science, 2006, 26(32): 111-115 DOI:10.1007/BF02828054

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WangJ, LinL, ParkashV P, et al.. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Int J Cancer, 2003, 103: 328-334

[2]

SyedV, UlinskiG, MokS C, et al.. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res, 2001, 61: 6768-6776

[3]

FengY J, ZhangX Y, GeB Q, et al.. The effects of gonadotrophin on the cell proliferation of ovarian epithelial cancer. Chin J Obstet Gynecol (Chinese), 1996, 3: 166-166

[4]

LiM E, PengZ L, ZhangP H. The expression and clinical significance of PCNA in ovarian serosity tumors. J Shanxi Med Coll (Chinese), 2002, 4: 101-102

[5]

ZhangN. The expression of VEGF and PCNA in ovarian epithelial tumors. J Diag Pathol (Chinese), 2004, 10: 340-342

[6]

O'ShaughnessyP J, DudjeyK, RajapakshaW R. Expression of follicle stimulating hormone-receptor mRNA during gonadal development. Mol Cell Endocrinol, 1996, 125(122): 169-175

[7]

TakahshiH, StruttonGM, ParsonsP C, et al.. Determination of proliferating fractins in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology, 1991, 18: 221-221

[8]

JiangJ, WangY, WangR. The relationship between the expression of PCNA and the prognosis of ovarian epithelial cancer. Chin J Exp Diag (Chinese), 1998, 6: 104-105

[9]

KraemerS, JaegerW H, LangN. Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer. Anticancer Res, 2001, 21: 2005-2010

[10]

ZhengW, LuJ, LuoF, et al.. Ovarian epithelial tumor growth promotion by follicle-stumilating hormone and inhibition of the effect by luteinzing hormone. Gynecol Oncol, 2000, 76: 80-88

[11]

ZhengW, MagidM S, KramerE E, et al.. Follicle-stimulating hormone recptor is expressed in human ovarian surface epithelium and fallopian tube. AmJ Pathol, 1996, 148: 47-53

[12]

ShenZ, FangM. The biochemistry characteristics of FSHR and its expression and regulation. Modern J Obstet Gynecol Advanced (Chinese), 2004, 13: 137-139

[13]

ZhuC, WangY, NixonM D, et al.. Antisense oligode-oxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor. Mol Reprod Dev, 2003, 65: 188-193

[14]

ZhuC, XiongZ, XiaoH. The effects of antisense oligodeoxynucleotide on the expression of recombinant porcine follicle-stimulating hormone receptor. National J Androl (Chinesc), 2000, 3: 146-149

AI Summary AI Mindmap
PDF

98

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/